Genetiniai sprendimai - Company finances
|
EUR
|
2021
From: 2021-10-20
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 1,653 | 57,200 | 191,224 | 409,902 | 463,573 |
| Profit before tax | 630 | -3,309 | 54,307 | 137,638 | 156,750 |
| Net profit | 630 | -3,309 | 51,725 | 132,705 | 148,031 |
| Equity | 3,130 | -179 | 54,855 | 187,560 | 300,491 |
| Liabilities | 0 | 5,381 | 62,529 | 56,028 | 40,031 |
| Non-current assets | 0 | 0 | 60,000 | 103,750 | 117,750 |
| Current assets | 3,306 | 5,202 | 57,384 | 139,827 | 222,756 |
| Total assets | 3,306 | 5,202 | 117,384 | 243,577 | 340,506 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 3,854 | 8,028 | 26,509 |
| Social insurance contributions | - | - | 5,277 | 7,615 | 4,924 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | +3360.4% | +234.3% | +114.4% | +13.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 19.1% | -63.6% | 44.1% | 54.5% | 43.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 20.1% | - | 94.3% | 70.8% | 49.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 38.1% | -5.8% | 27.0% | 32.4% | 31.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 38.1% | -5.8% | 28.4% | 33.6% | 33.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 1.1 | 0.3 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 827 | 17,600 | 43,296 | 74,528 | 115,893 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Genetiniai sprendimai - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-03-18 | 2024-04-07 | 0.20 |
| 2024-02-19 | 2024-03-06 | 0.20 |
| 2024-01-23 | 2024-02-06 | 0.20 |
| 2023-10-17 | 2023-10-19 | 172.56 |
| 2022-11-21 | 2022-12-06 | 0.33 |
| 2022-11-17 | 2022-11-18 | 0.33 |
Genetiniai sprendimai - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-04-04 | 2025-04-04 | 340.09 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Genetiniai sprendimai, UAB (code 305920265) is a Private Limited Liability Company engaged in diagnostic imaging services and medical laboratory activities. In 2025, the company generated EUR 463.6K in revenue, up 13.1% year on year and 142.4% compared with 2023. Net profit reached EUR 148.0K in 2025, compared with EUR 132.7K in 2024 and EUR 51.7K in 2023, showing a clear upward three-year trajectory. Profit margin remained high at 31.9% in 2025, after 32.4% in 2024 and 27.0% in 2023. The balance sheet also expanded: total assets increased to EUR 340.5K in 2025 from EUR 243.6K in 2024 and EUR 117.4K in 2023. Equity rose to EUR 300.5K, while liabilities declined to EUR 40.0K. The equity ratio stood at 88.2%, and debt to equity was 0.13. Asset turnover was 1.36x. In 2025, revenue per employee was EUR 115.9K and profit per employee EUR 37.0K, indicating solid operating productivity.